Hurwitz JL - Search Results

1

Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccine.

Sealy R, Slobod KS, Flynn P, Branum K, Surman S, Jones B, Freiden P, Lockey T, Howlett N, Hurwitz JL. Sealy R, et al. Among authors: hurwitz jl. Int Rev Immunol. 2009;28(1):49-68. doi: 10.1080/08830180802495605. Int Rev Immunol. 2009. PMID: 19241253 Free PMC article. Review.

2

Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells.

Dave VP, Allan JE, Slobod KS, Smith FS, Ryan KW, Takimoto T, Power UF, Portner A, Hurwitz JL. Dave VP, et al. Among authors: hurwitz jl. Virology. 1994 Mar;199(2):376-83. doi: 10.1006/viro.1994.1135. Virology. 1994. PMID: 7510085

3

Does envelope V3 peptide comprise the principal neutralizing determinant for HIV?

Slobod KS, Hurwitz JL. Slobod KS, et al. Among authors: hurwitz jl. Vaccine. 1995 Jan;13(1):129. doi: 10.1016/0264-410x(95)80027-b. Vaccine. 1995. PMID: 7539198 No abstract available.

4

Peripheral T cell receptor repertoire among CD4+ and CD8+ subsets during acute infectious mononucleosis.

Slobod KS, Leggiadro RJ, Presbury G, Smith FS, Hurwitz JL. Slobod KS, et al. Among authors: hurwitz jl. Viral Immunol. 1994;7(3):151-3. doi: 10.1089/vim.1994.7.151. Viral Immunol. 1994. PMID: 7598788 No abstract available.

5

Activity of transplanted CD8+ versus CD4+ cytotoxic T cells against Epstein-Barr virus-immortalized B cell tumors in SCID mice.

Rencher SD, Slobod KS, Smith FS, Hurwitz JL. Rencher SD, et al. Among authors: hurwitz jl. Transplantation. 1994 Sep 15;58(5):629-33. doi: 10.1097/00007890-199409150-00020. Transplantation. 1994. PMID: 7916506 No abstract available.

6

HIV type 1 envelope sequence diversity in inner city community.

Slobod KS, Rencher SD, Farmer A, Smith FS, Hurwitz JL. Slobod KS, et al. Among authors: hurwitz jl. AIDS Res Hum Retroviruses. 1994 Jul;10(7):873-5. doi: 10.1089/aid.1994.10.873. AIDS Res Hum Retroviruses. 1994. PMID: 7986592 No abstract available.

7

T-cell receptor heterogeneity among Epstein-Barr virus-stimulated T-cell populations.

Slobod KS, Freiberg AS, Allan JE, Rencher SD, Hurwitz JL. Slobod KS, et al. Among authors: hurwitz jl. Virology. 1993 Sep;196(1):179-89. doi: 10.1006/viro.1993.1466. Virology. 1993. PMID: 8395113

8

Does the key to a successful HIV type 1 vaccine lie among the envelope sequences of infected individuals?

Rencher SD, Slobod KS, Dawson DH, Lockey TD, Hurwitz JL. Rencher SD, et al. Among authors: hurwitz jl. AIDS Res Hum Retroviruses. 1995 Sep;11(9):1131-3. doi: 10.1089/aid.1995.11.1131. AIDS Res Hum Retroviruses. 1995. PMID: 8554911 No abstract available.

9

Eliminating graft-versus-host potential from T cell immunotherapeutic populations.

Rencher SD, Houston JA, Lockey TD, Hurwitz JL. Rencher SD, et al. Among authors: hurwitz jl. Bone Marrow Transplant. 1996 Aug;18(2):415-20. Bone Marrow Transplant. 1996. PMID: 8864455

10

Fluctuating diversity in the HTLV-IIIB virus stock: implications for neutralization and challenge experiments.

Lockey TD, Slobod KS, Rencher SD, Srinivas RV, Hurwitz JL. Lockey TD, et al. Among authors: hurwitz jl. AIDS Res Hum Retroviruses. 1996 Sep 1;12(13):1297-9. doi: 10.1089/aid.1996.12.1297. AIDS Res Hum Retroviruses. 1996. PMID: 8870852 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters